Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial-Reference-Cited by-同舟云学术

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Published:2013-03 Issue:9871 Volume:381 Page:1021-1028
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Tameris Michele D,Hatherill Mark,Landry Bernard S,Scriba Thomas J,Snowden Margaret Ann,Lockhart Stephen,Shea Jacqueline E,McClain J Bruce,Hussey Gregory D,Hanekom Willem A,Mahomed Hassan,McShane Helen

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness;Trunz;Lancet,2006

2. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis;Rodrigues;Int J Epidemiol,1993

3. Variation in protection by BCG: implications of and for heterologous immunity;Fine;Lancet,1995

4. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature;Colditz;Pediatrics,1995

5. Identifying predictors of interferon-gamma release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study;Basu Roy;Am J Respir Crit Care Med,2012

Cited by 867 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shared challenges to the control of complex intracellular neglected pathogens;Frontiers in Public Health;2024-09-11

2. Recent efforts in the development of glycoconjugate vaccine and available treatment for tuberculosis;Bioorganic Chemistry;2024-09

3. Mapping Human Immunity and the Education of Waldeyer's Ring;Annual Review of Genomics and Human Genetics;2024-08-27

4. A noninvasive BCG skin challenge model for assessing tuberculosis vaccine efficacy;PLOS Biology;2024-08-19

5. Trends in Viral Vector-Based Vaccines for Tuberculosis: A Patent Review (2010–2023);Vaccines;2024-08-02